Given the dysfunctional role of SOD enzymes in Alzheimer’s disease, it is possible that an infusion of Tregs would have a limited effect as they become unstable from ROS, and it may be necessary to measure the antioxidant status of patients with Alzheimer’s disease before administering these novel treatments. This evidence concerns the gene SOD1 and Alzheimer disease.